We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

124 hedge funds and large institutions have $433M invested in Amedisys in 2013 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more call options, than puts

Call options by funds: $4.09M | Put options by funds: $1.62M

25% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 40

5% less funds holding

Funds holding: 130124 (-6)

11% less capital invested

Capital invested by funds: $486M → $433M (-$53M)

24% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 21

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
124
Holders Change
-6
Holders Change %
-4.62%
% of All Funds
3.6%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
16
Increased
50
Reduced
40
Closed
21
Calls
$4.09M
Puts
$1.62M
Net Calls
+$2.47M
Net Calls Change
-$9.05M
Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$70.8M +$77.9M +4,836,608 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$64.1M
NTC
3
North Tide Capital
Massachusetts
$46.8M +$7.25M +450,000 +16%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$30.8M +$3.84M +238,339 +13%
BFA
5
BlackRock Fund Advisors
California
$28.2M +$982K +61,003 +3%
Vanguard Group
6
Vanguard Group
Pennsylvania
$28M +$1.71M +106,382 +6%
Wells Fargo
7
Wells Fargo
California
$17.7M -$4.15M -257,945 -18%
BIT
8
BlackRock Institutional Trust
California
$13.5M +$337K +20,941 +2%
Northern Trust
9
Northern Trust
Illinois
$10.8M +$302K +18,761 +3%
State Street
10
State Street
Massachusetts
$10.1M +$241K +14,954 +2%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$8.13M +$174K +10,792 +2%
JP Morgan Chase
12
JP Morgan Chase
New York
$7.38M -$315K -19,593 -4%
Norges Bank
13
Norges Bank
Norway
$4.63M
Bank of New York Mellon
14
Bank of New York Mellon
New York
$4.31M +$8.9K +553 +0.2%
CCP
15
Clough Capital Partners
Massachusetts
$3.99M +$4.39M +272,800 New
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$3.83M -$17.8K -1,108 -0.4%
Connor, Clark & Lunn Investment Management (CC&L)
17
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.51M +$969K +60,200 +36%
TC
18
TFS Capital
Pennsylvania
$3.27M -$2.16M -134,236 -37%
BIP
19
Brandes Investment Partners
California
$3.15M -$218K -13,525 -6%
Invesco
20
Invesco
Georgia
$3.15M -$1.42M -88,162 -29%
TCIM
21
TIAA CREF Investment Management
New York
$3.12M -$44.1K -2,740 -1%
BCM
22
Bridgeway Capital Management
Texas
$2.98M +$1.88M +116,900 +134%
Principal Financial Group
23
Principal Financial Group
Iowa
$2.77M +$215K +13,359 +8%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$2.43M +$2.67M +165,900 New
Charles Schwab
25
Charles Schwab
California
$2.31M +$222K +13,776 +10%

AMED Hedge Fund Activity: Q4 2013 in Review

124 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2013, worth a combined $433M — down 11% from $486M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of AMED and 16 opened new positions — a net loss of 5 holders — while 40 trimmed existing stakes and 50 added.

The largest buyer was Kohlberg Kravis Roberts & Co, opening a new position worth an estimated $77.9M. The largest seller was Teachers Advisors, cutting an estimated $6.27M.

  • 124 institutional investors held Amedisys (AMED) as of Q4 2013, down from 130 in Q3 2013.
  • Funds reported $433M of Amedisys stock for Q4 2013, down 11% quarter-over-quarter.
  • 16 funds opened new Amedisys positions in Q4 2013 and 21 closed out, a net change of -5 holders.
  • The largest Amedisys buyer in Q4 2013 was Kohlberg Kravis Roberts & Co, an estimated $77.9M added.
  • The largest Amedisys seller in Q4 2013 was Teachers Advisors, an estimated $6.27M sold.

Based on aggregated 13F filings for Q4 2013.